Judit Peix

5.0k total citations
10 papers, 657 citations indexed

About

Judit Peix is a scholar working on Oncology, Cancer Research and Hepatology. According to data from OpenAlex, Judit Peix has authored 10 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Cancer Research and 4 papers in Hepatology. Recurrent topics in Judit Peix's work include Pancreatic and Hepatic Oncology Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Judit Peix is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Judit Peix collaborates with scholars based in Spain, United States and Italy. Judit Peix's co-authors include Josep M. Llovet, Augusto Villanueva, Laia Cabellos, Victoria Tovar, Manel Solé, Daniela Sia, Yujin Hoshida, Clara Alsinet, Vincenzo Mazzaferro and Agrin Moeini and has published in prestigious journals such as Gastroenterology, Hepatology and Cancer Research.

In The Last Decade

Judit Peix

9 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judit Peix Spain 7 307 298 240 157 133 10 657
Quentin Bayard France 9 302 1.0× 185 0.6× 245 1.0× 105 0.7× 162 1.2× 13 630
Sara Torrecilla Spain 6 252 0.8× 212 0.7× 206 0.9× 121 0.8× 82 0.6× 10 512
Yacine Hajji France 4 157 0.5× 319 1.1× 194 0.8× 117 0.7× 217 1.6× 4 606
Iris Martinez-Quetglas Spain 5 331 1.1× 423 1.4× 305 1.3× 410 2.6× 154 1.2× 8 1.0k
Bin-yong Liang China 15 253 0.8× 291 1.0× 129 0.5× 154 1.0× 178 1.3× 32 656
Olga Kuchuk Ukraine 3 192 0.6× 300 1.0× 176 0.7× 333 2.1× 110 0.8× 10 715
Van Chanh Ngo Singapore 6 319 1.0× 250 0.8× 103 0.4× 111 0.7× 56 0.4× 6 570
Yong‐Fa Zhang China 17 158 0.5× 397 1.3× 174 0.7× 160 1.0× 194 1.5× 32 654
Hiroaki Hagihara Japan 13 144 0.5× 253 0.8× 93 0.4× 72 0.5× 159 1.2× 25 427
Kevin Perraud Switzerland 4 144 0.5× 346 1.2× 105 0.4× 133 0.8× 136 1.0× 6 516

Countries citing papers authored by Judit Peix

Since Specialization
Citations

This map shows the geographic impact of Judit Peix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Peix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Peix more than expected).

Fields of papers citing papers by Judit Peix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Peix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Peix. The network helps show where Judit Peix may publish in the future.

Co-authorship network of co-authors of Judit Peix

This figure shows the co-authorship network connecting the top 25 collaborators of Judit Peix. A scholar is included among the top collaborators of Judit Peix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judit Peix. Judit Peix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Torrens, Laura, Carla Montironi, Marc Puigvehí, et al.. (2021). Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma. Hepatology. 74(5). 2652–2669. 107 indexed citations
2.
Hernandez‐Meza, Gabriela, Johann von Felden, Edgar Gonzalez‐Kozlova, et al.. (2020). DNA Methylation Profiling of Human Hepatocarcinogenesis. Hepatology. 74(1). 183–199. 71 indexed citations
3.
Esteban-Fabró, Roger, Catherine E. Willoughby, Marta Piqué‐Gili, et al.. (2020). Cabozantinib enhances the efficacy and immune modulatory activity of anti-PD1 therapy in a syngeneic mouse model of hepatocellular carcinoma. Journal of Hepatology. 73. S40–S40. 6 indexed citations
4.
Moeini, Agrin, Sara Torrecilla, Victoria Tovar, et al.. (2019). An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents. Gastroenterology. 157(5). 1383–1397.e11. 62 indexed citations
5.
Montal, Robert, Carmen Andreu-Oller, Laia Bassaganyas, et al.. (2019). Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials. British Journal of Cancer. 121(4). 340–343. 63 indexed citations
6.
Tovar, Victoria, Helena Cornellà, Agrin Moeini, et al.. (2015). Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma. Gut. 66(3). 530–540. 160 indexed citations
7.
Martinez-Quetglas, Iris, Roser Pinyol, Daniel Dauch, et al.. (2015). P0265 : IGF2 is an oncogenic driver in HCC and emerges as a potential target for therapies. Journal of Hepatology. 62. S405–S406.
8.
Tovar, Victoria, Clara Alsinet, Augusto Villanueva, et al.. (2010). IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. Journal of Hepatology. 52(4). 550–559. 186 indexed citations
9.
Tovar, Victoria, Clara Alsinet, Augusto Villanueva, et al.. (2010). Abstract LB-233: IGF activation in a molecular subclass of hepatocellular carcinoma and preclinical efficacy of IGF-1R blockage. Cancer Research. 70(8_Supplement). LB–233. 1 indexed citations
10.
Chiang, Derek Y., Yoshihiko Hoshida, Judit Peix, et al.. (2008). 24 A NOVEL MOLECULAR CLASSIFICATION OF HCV-RELATED HEPATOCELLULAR CARCINOMA (HCC) BASED ON INTEGRATIVE GENOMIC ANALYSIS. Journal of Hepatology. 48. S12–S12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quentin Bayard Breakdown of academic impact, for papers by Sara Torrecilla Breakdown of academic impact, for papers by Yacine Hajji Breakdown of academic impact, for papers by Iris Martinez-Quetglas Breakdown of academic impact, for papers by Bin-yong Liang Breakdown of academic impact, for papers by Olga Kuchuk Breakdown of academic impact, for papers by Van Chanh Ngo Breakdown of academic impact, for papers by Yong‐Fa Zhang Breakdown of academic impact, for papers by Hiroaki Hagihara Breakdown of academic impact, for papers by Kevin Perraud
Rankless by CCL
2026